RxDoctor Payments Data

Elinor Berry

Physician Assistant · Springfield, ILNPI 1578664801

Payments from drug & device makers

$4,288in general payments, 2019–2025

Across 207 payments — averaging $20.71 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$891
  • GSK$852
  • Inspire Medical Systems, Inc.$641
  • Regeneron Healthcare Solutions, Inc.$317
  • Boehringer Ingelheim$273
  • Mylan Specialty L.p.$174
  • plus $1K from 17 others

What the payments were for

  • Food & beverage$4,288100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$4,288 in reported general payments places this provider in the 90th percentile of 3,912 physician assistant providers in Illinois.

See all physician assistant providers in Illinois

Medicare billing

Part B allowed, 2024
$64,582
Medicare patients
420
Services billed
795

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Trelegy ElliptaFluticasone/Umeclidin/Vilanter222$178,958
Anoro ElliptaUmeclidinium Brm/Vilanterol Tr61$40,113
Breo ElliptaFluticasone/Vilanterol40$26,570
Spiriva RespimatTiotropium Bromide25$20,199
Breztri AerosphereBudesonide/Glycopyr/Formoterol25$16,001
Fluticasone-SalmeterolFluticasone Propion/Salmeterol77$11,803
Budesonide-Formoterol FumarateBudesonide/Formoterol Fumarate27$6,122
SymbicortBudesonide/Formoterol Fumarate17$5,636
Albuterol Sulfate HfaAlbuterol Sulfate203$4,963
Wixela InhubFluticasone Propion/Salmeterol27$4,366
Ventolin HfaAlbuterol Sulfate21$1,315
Montelukast Sodium128$894
Azelastine Hcl12$631
Fluticasone Propionate45$623
Albuterol Sulfate13$598

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
GSKTrelegy Ellipta, Anoro Ellipta, Breo Ellipta$852$245,642323 claims
AstraZenecaBreztri Aerosphere, Symbicort$891$21,63742 claims
Boehringer IngelheimSpiriva Respimat$273$20,19925 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 3,912 physician assistant providers in Illinois.

Other physician assistant in Springfield

See the full list for Illinois

Where these figures come from

Is this you, or does something look wrong? →